Balance Sheet Details

12 Months Ended

Dec. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Details

4. Balance Sheet Details

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):

	December 31, 2021		December 31, 2020
Prepaid contract manufacturing expenses	$	3,808	$	121
Prepaid clinical trial expenses		1,397		998
Prepaid research and development expenses		627		775
Other prepaid expenses		1,218		275
Total	$	7,050	$	2,169

Equipment, Net

Equipment, net, consist of the following (in thousands):

	December 31, 2021			December 31, 2020
Laboratory equipment	$	1,830		$	572
Office equipment and furniture		24			24
		1,854			596
Less accumulated depreciation		(407	)		(149	)
Total	$	1,447		$	447

Depreciation expense related to property and equipment was $0.3 million and $0.1 million for the years ended December 31, 2021 and 2020, respectively.

Accrued Compensation

Accrued compensation consist of the following (in thousands).

	December 31, 2021		December 31, 2020
Accrued salaries and payroll taxes	$	64	$	402
Accrued vacation		—		102
Accrued employee stock purchase plan contributions		129		—
Accrued bonuses		5,024		1,556
Accrued severance		161		662
Total	$	5,378	$	2,722

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	December 31, 2021		December 31, 2020
Accrued research and development expenses	$	2,123	$	216
Accrued clinical trial expenses		1,999		109
Accrued contract manufacturing expenses		906		1,343
Accrued legal expenses		531		490
Unvested early exercise liability		35		67
Accrued other		456		669
Total	$	6,050	$	2,894